|
|
Drug-device combination products (DDCPs) leverage new technologies that provide advantages for patients, such as self-administration conveniences and safety, and, for payers, improved adherence. Examine how to establish a holistic approach to DDCP development and how to assess and manage risk throughout the development and approval process.
|